Surgery for early stage esophageal adenocarcinoma

Journal of Surgical Oncology

Volumn 92, Issue 3, 2005, Pages 210-217

  Stein, H J ^a   Von Rahden, B H A ^b   Feith, M ^b  

^a University Hospital Salzburg   (Austria)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adenocarcinoma of the distal esophagus; Barrett cancer; Early cancer; Esophageal cancer; Esophagectomy; Lymph node metastases; Lymphadenectomy; Prognosis; Prognostic factors; Sentinel node

Indexed keywords

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER RECURRENCE; CANCER SURGERY; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CARCINOMA, SQUAMOUS CELL; CATHETER ABLATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MUCOUS MEMBRANE; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 28844503548     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20362     Document Type: Review

References (50)

1. Stein HJ, Feith M, Siewert JR: Malignant degeneration of Barrett's esophagus: Clinical point of view. Recent Results Cancer Res 2000;155:42-53.
2. Flejou JF: Barrett's oesophagus: From metaplasia to dysplasia and cancer. Gut 2005;54:i6-i12.
3. Spechler SJ: Barrett's esophagus. New Engl J Med 2002;346: 836-842.
4. Sharma P, Sidorenko EI: Are screening and surveillance for Barrett's oesophagus really worthwhile? Gut 2005;54:i27-i32.
5. Peters JH, Clark GW, Ireland AP, et al.: Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994;108:813-822.
6. van Sandick JW, van Lanschot JJ, Kuiken BW, et al.: Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998;43:216-222.
7. Stein HJ, Feith M, Müller J, et al.: Limited resection for early Barrett's cancer. Ann Surg 2000;232:733-742.
8. Stein HJ, Feith M, von Rahden BH, et al.: Approach to early Barrett's cancer. World J Surg 2003;27:1040-1046.
9. Buttar NS, Wang KK, Lutzke LS, et al.: Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc 2001;54:682-838.
10. Ell C, May A, Gossner L, et al.: Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118:670-677.
11. May A, Gossner L, Pech O, et al.: Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: Acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002;14: 1085-1091.
12. May A, Gossner L, Pech O, et al.: Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): Curative treatment using local endoscopic treatment techniques. Endoscopy 2002;34:604-610.
13. Ormsby AH, Petras RE, Henricks WH, et al: Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 2002;51:671-676.
14. Schlemper RJ, Riddell RH, Kato Y, et al.: The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-255.
15. Werner M, Flejou JF, Hainaut P, et al.: Adenocarcinoma of the oesophagus. In: Hamilton SR, Aaltonen L, editors. World Health Organization Classification of Tumours: Patholgy and genetics-tumours of the digestive system. Lyon: IARC Press; 2000. pp 20-25.
16. Schnell TG, Sontag SJ, Chejfec G, et al.: Long-term nonsurgical management of Barrett's esophagus with high grade dysplasia. Gastroenterology 2001;120:1607-1619.
17. Stein HJ: Panel of experts: Esophageal cancer: Screening and surveillance. Results of a consensus conference. Dis Esoph 1996; 9:3-19.
18. Reid BJ, Levine DS, Longton G, et al.: Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 2000;95:1669-1676.
19. Collard JM: High-grade dysplasia in Barrett's esophagus. The case for esophagectomy. Chest Surg Clin N Am 2002;12:77-92.
20. Holscher AH, Bollschweiler E, Schneider PM, et al.: Early adenocarcinoma in Barrett's oesophagus. Br J Surg 1997;84:1470-1473.
21. Headrick JR, Nichols FC, Miller DL, et al.: High-grade esophageal dysplasia: Long-term survival and quality of life after esophagectomy. Ann Thor Surg 2002;73:1697-1703.
22. Lerut T, Nafteux P, Moons J, et al.: Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: Impact on staging, disease-free survival, and outcome: A plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 2004;240:962-972.
23. Altorki N, Kent M, Ferrara C, et al: Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177-183.
24. Kirby JD: Quality of life after oesophagectomy: The patients' perspective. Dis Esophagus 1999;12:168-171.
25. Fernando HC, Luketich JD, Buenaventura PO, et al.: Outcomes of minimally invasive esophagectomy (MIE) for high-grade dysplasia of the esophagus. Eur J Cardiothorac Surg 2002;22:1-6.
26. Banki F, Mason R, DeMeester SR, et al.: Vagal-sparing esophagectomy: A more physiologic alternative. Ann Surg 2002; 236:324-336.
27. van Sandick JW, van Lanschot JJ, ten Kate FJ, et al.: Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: Implications for therapeutic decision making. Cancer 2000;88:2429-2437.
28. Buttar NS, Wang KK, Sebo TJ, et al.: Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001;120:1630-1639.
29. Stein HJ, Feith M, Brücher BLDM, Nährig J, Siewert JR.: Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005 (in press).
30. Nigro JJ, Hagen JA, DeMeester TR, et al.: Occult esophageal adenocarcinoma: Extent of disease and implications for effective therapy. Ann Surg 1999;230:433-438.
31. Streitz JM, Jr., Ellis FH, Jr., Gibb SP, et al.: Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg 1991;213:122-125.
32. Buskens CJ, Westerterp M, Lagarde SM, et al.: Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 2004;60:703-710.
33. Rice TW, Blackstone EH, Goldblum JR, et al.: Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 2001;122:1077-1090.
34. Nigro JJ, Hagen JA, DeMeester TR, et al.: Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg 1999;117:16-23.
35. Brücher BLDM, Stein HJ, Werner M, et al.: Lymphatic vessel invasion is an independent prognostic factor in patients with primary resected esophageal squamous cell cancer. Cancer 2001; 92:2228-2233.
36. v Rahden BHA, Stein HJ, Feith M, et al.: Lymphatic vessel invasion as prognostic factor in patients with primary resected adenocarcinoma of the esophagogastric junction. J Clin Oncol 2005;23:874-879.
37. May A, Gunter E, Roth F, et al.: Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: A comparative, prospective, and blinded trial. Gut 2004;53:634-640.
38. Vieth M, Ell C, Gossner L, et al.: Histological analysis of endoscopic resection specimens from 326 patients with Barrett's esophagus and early neoplasia. Endoscopy 2004;36:776-781.
39. Merendino KA, Dillard DH: The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiological abnormalities at the esophagogastric junction. Ann Surg 1955; 142:486-506.
40. Siewert JR, Stein HJ: Lymphadenectomy for esophageal cancer. Langenbeck's Arch Surg 1999;384:141-148.
41. Takeshita K, Saito N, Saeki I, et al.: Proximal gastrectomy and jejunal pouch interposition for the treatment of early cancer in the upper third of the stomach: Surgical techniques and evaluation of postoperative function. Surgery 1997;121:278-286.
42. Gaissert HA, Mathisen DJ, Grillo HC, et al.: Short-segment intestinal interposition of the distal esophagus. J Thorac Cardiovasc Surg 1993;106:860-866.
43. Gerzic ZB: Modification of the Merendino procedure. Dis Esophagus 1997;10:270-275.
44. Mansour KA, Bryan FC, Carlson GW: Bowel interposition for esophageal replacement: Twenty-five-year experience. Ann Thorac Surg 1997;64:752-756.
45. Maish MS, DeMeester SR: Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Ann Thorac Surg 2004;78:1777-1782.
46. Ueno H, Hirai T, Nishimoto N, et al.: Prediction of lymph node metastasis by p53, p21(Wafl), and PCNA expression in esophageal cancer patients. J Exp Clin Cancer Res 2003;22:239-245.
47. Kan T, Shimada Y, Sato F, et al.: Prediction of lymph node metastasis with use of artificial neural networks based on gene expression profiles in esophageal squamous cell carcinoma. Ann Surg Oncol 2004;11:1070-1078.
48. Burian M, Stein HJ, Sendler A, et al.: Sentinel node detection in Barrett's and cardia cancer. Ann Surg Oncol 2004;11:255-258.
49. Lamb PJ, Griffin SM, Burt AD, et al.: Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg 2005;92:60-67.
50. Kato H, Miyazaki T, Nakajima M, et al.: Sentinel lymph nodes with technetium-99m colloidal rhenium sulfide in patients with esophageal carcinoma. Cancer 2003;98:932-939.